Reports

Sale

Assisted Reproductive Technology Market

Global Assisted Reproductive Technology Market Size, Growth: By Procedure: Fresh Donor, Fresh Nondonor, Frozen Donor, Frozen Nondonor, Embryo/Egg Banking; By Age: Women Younger Than Age 35, Women Older Than Age 35; By Application; By End User; Regional Analysis; Patent Analysis; Grants Analysis; Supplier Landscape; 2024-2032

Global Assisted Reproductive Technology Market Outlook

The global assisted reproductive technology market size was valued at USD 15.14 billion in 2023, driven by the increasing infertility issues across the globe. The market size is anticipated to grow at a CAGR of 4.4% during the forecast period of 2024-2032 to achieve a value of USD 22.30 billion by 2032.

 

Global Assisted Reproductive Technology Market Overview

The increasing advancements in the field by key players are expected to drive the growth of the market in the coming years. The expanding applications of AI in assisted reproductive technology (ART) are expected to further propel the market demand. Advanced technologies, such as precision 3D printing and advanced microscopes, are expected to assist in identifying embryos and promoting healthy pregnancy, further propelling the global assisted reproduction technology market demand.

 

The rapidly advancing technology is enabling people to conceive even when they are having medical issues. Such advanced technologies are directly contributing to the increasing demand, further fuelling the market growth. A few examples of assisted reproductive technologies include In-vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), Intrauterine Insemination (IUI), Gamete Intrafallopian Transfer (GIFT), and Zygote Intrafallopian Transfer (ZIFT), among others.

 

assisted reproductive technology market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

A significant rise in the adoption of these advancing technologies for broader adoption with increasing awareness among healthcare professionals is expected to propel the market growth. The rising cases of infertility worldwide are leading to the increased adoption of assisted reproduction technology (ART), contributing significantly to the assisted reproductive technology market share. The high success rates of ART across the globe are gaining traction while providing hope to people who have some medical issues but look forward to conceiving in the coming future. The increasing disposable income among people mostly in developing countries is also contributing to the market growth.

 

Rising Prevalence of Infertility

The growth of the market is primarily driven by the rising prevalence of infertility and other reproductive issues across the world. Infertility affects  millions of people every year, one in every six people of reproductive age, which is nearly 17.5% of the total adult population, is affected by infertility in their life. Assisted reproductive technologies have been in the market for over three decades and have intervened in the birth of more than 5 million children across the world. These technologies are still widely inaccessible because of the price point, which is unaffordable for majority of the population, especially in low-income countries.

 

Technological Advancements Bolstering the Assisted Reproductive Technology Market Growth

The key players in the market are focusing on developing advanced healthcare systems to assist people in need of assisted reproduction technology, which is further expected to greatly influence the assisted reproduction technology market demand. Technologies like machine learning models are being introduced in the market to optimise hormonal treatments, including FSH (follicle-stimulating hormone) for better results. Other than that, various innovative platforms have been working on enabling remote monitoring and testing, various efforts are being made in electronic witnessing systems and robotic cryopreservation systems, which can help streamline the whole system of tracking and preserving eggs, sperms, and embryos. AI tools are one of the biggest developments in the healthcare sector, these tools are widely being used to enhance the fertility outcomes and make it more cost-effective. For instance, in October 2022, Alife, after doing thorough research and development for over two years, introduced a new AI based software that can aid fertility clinics to improve fertility outcomes by optimising and supporting the critical decisions during the process of IVF.

 

Global Recognition by Regulatory Authorities to Act as a Key Driver for the Assisted Reproductive Technology Market Growth

In April 2023, TMRW Life Sciences, a fertility technology company automating the IVF lab, announced  receiving a CE Mark for the CryoRobot Select (CRS). The European designation follows clearance by the U.S. Food and Drug Administration, and the two regulatory achievements demonstrate that TMRW's automated platform for the safe management and storage of frozen eggs and embryos is now the global standard. TMRW’s recognition as a global standard is expected to increase the widespread adaptation of this technology to make the whole process safer and more standardized.

 

Strategic Acquisition Activities by Key Players

The rising competition amongst the key players is also aiding the assisted reproductive technology market growth. In July 2023, Baring Private Equity Asia (BPEA) EQT agreed to acquire a controlling stake in Indira IVF from TA Associates and the company’s founders. BPEA EQT is expected to acquire a 60% stake for USD 656.6 million. As India is one of the fastest-growing markets globally for assisted reproductive technology services, this acquisition is further anticipated to increase the market reach in more developed markets with this acquisition, driving the market growth.

 

Rising Support from the Government to Support the Growth of the Assisted Reproductive Technology Market

The growth of the market is driven by the increasing initiatives by governments towards the regulation of practices as safe and effective for the people acquiring assistance from such services. For instance, In April 2023, the Ministry of Health and Family Welfare (MoHFW) rolled back the manner of retrieving oocytes and placing embryos vide assisted reproductive technology regulations in a manner where the health of the patient would not be compromised.

 

Additionally, In June 2023, the government of Beijing announced that they will cover 16 types of assisted reproduction technology under the city's health care system. This is an effort to boost China's declining birth rate. In-vitro fertilisation, embryo transplantation, freezing, and storing semen are some of the treatments that will be included under basic insurance. This initiative by the government is expected to drive the market growth by encouraging people to have babies.  The expenses of these services will be covered under health insurance, making it more convenient for people to avail of the services. This change is expected to increase the adaptation and demand for these services in the market during the forecast period. It could potentially lead to more people using these methods to have babies, which in turn could increase the number of births in Beijing.

 

assisted reproductive technology market by segment

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Global Assisted Reproductive Technology Market Segmentations

Market Breakup by Procedure

  • Fresh Donor
  • Fresh Nondonor
  • Frozen Donor
  • Frozen Nondonor
  • Embryo/Egg Banking

 

Market Breakup by Age

  • Women Younger than age 35
  • Women Older than age 35

 

Market Breakup by Application

  • Artificial Insemination - Intrauterine Insemination (AI-IUI)
  • Frozen Embryo Replacement (FER)
  • Surrogacy
  • Ovulation Induction
  • Others

 

Market Breakup by End User

  • Hospitals
  • Fertility Clinics
  • Others

 

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

 

Assisted Reproductive Technology Market Regional Analysis

North America has been leading the global market for assisted reproductive technology and it is likely to continue dominating the market in the forecast period. The region is anticipated to dominate in the forecast period due to the robust healthcare infrastructure and decreasing fertility, increasing research activities. The region is likely to continue dominating the global market owing to the presence of renowned clinics in the region.

 

In October 2023, Hamilton Thorne Ltd., a leading provider of precision instruments, consumables, software, and services to the Assisted Reproductive Technologies ("ART") research and cell biology markets, announced that they have acquired Gynetics Medical Products, N.V. and Gynetics Services B.V. (collectively, "Gynetics"). Gynetics, based in Lommel, Belgium is a leading manufacturer of a wide range of innovative, high-quality In Vitro Fertilization ("IVF") devices in the global IVF market. The acquisition is poised to highlight Hamilton Thorne's consumables product offerings and increase the market reach for profitable operations in the well-established European ART market.

 

assisted reproductive technology market by region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Assisted Reproductive Technology Market: Competitor Landscape

In June 2023, FUJIFILM Irvine Scientific, Inc., a global leader in the innovation and manufacture of cell culture solutions for the Life Science and Medical markets, announced the addition of the Life Whisperer Genetics module to its Life Whisperer software package, enabling non-invasive evaluation of embryo genetic integrity during in vitro fertilization (IVF). Life Whisperer Genetics, when combined with Life Whisperer Viability, offers a distinctive way to help choose blastocysts during clinical processes. This combined platform helps identify blastocysts with a higher chance of being euploid and leading to successful pregnancies, all within a single system.

 

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players.

 

The major companies in the assisted reproductive technology market are as follows:

 

  • California Cryobank
  • Bloom Fertility Centre
  • Anecova
  • CooperSurgical
  • Merck KGaA
  • Ferring B.V.
  • FUJIFILM Irvine Scientific
  • Genea Limited
  • Nidacon International AB
  • Celmatix Inc.

 

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Procedure
  • Age
  • Application
  • End User
  • Region
Breakup by Procedure
  • Fresh Donor
  • Fresh Nondonor
  • Frozen Donor
  • Frozen Nondonor
  • Embryo/Egg Banking
Breakup by Age
  • Women Younger Than Age 35
  • Women Older Than Age 35
Breakup by Application
  • Artificial Insemination - Intrauterine Insemination (AI-IUI)
  • Frozen Embryo Replacement (FER)
  • Surrogacy
  • Ovulation Induction
  • Others
Breakup by End User
  • Hospitals
  • Fertility Clinics
  • Others
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • California Cryobank
  • Bloom Fertility Centre
  • Anecova
  • CooperSurgical
  • Merck KGaA
  • Ferring B.V.
  • FUJIFILM Irvine Scientific
  • Genea Limited
  • Nidacon International AB
  • Celmatix Inc.

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions
    1.3    Report Coverage – Key Segmentation and Scope 
    1.4    Research Methodology
2    Executive Summary
3    Global Assisted Reproductive Technology Market Overview 

    3.1    Global Assisted Reproductive Technology Market Historical Value (2016-2022) 
    3.2    Global Assisted Reproductive Technology Market Forecast Value (2023-2031)
4    Global Assisted Reproductive Technology Market Landscape
    4.1    Global Assisted Reproductive Technology: Developers Landscape
        4.1.1    Analysis by Year of Establishment
        4.1.2    Analysis by Company Size
        4.1.3    Analysis by Region
    4.2    Global Assisted Reproductive Technology: Product Landscape
        4.2.1    Analysis by Type
        4.2.2    Analysis by Technology
        4.2.3    Analysis by Applications
5    Global Assisted Reproductive Technology Market Dynamics
    5.1    Market Drivers and Constraints
    5.2    SWOT Analysis
    5.3    Porter’s Five Forces Model
    5.4    Key Demand Indicators 
    5.5    Key Price Indicators
    5.6    Industry Events, Initiatives, and Trends  
    5.7    Value Chain Analysis
6    Global Assisted Reproductive Technology Market Segmentation
    6.1    Global Assisted Reproductive Technology Market by Procedure
        6.1.1    Market Overview
        6.1.2    Fresh Donor
        6.1.3    Fresh Nondonor
        6.1.4    Frozen Donor
        6.1.5    Frozen Nondonor
        6.1.6    Embryo/Egg Banking
    6.2    Global Assisted Reproductive Technology Market by Age
        6.2.1    Market Overview
        6.2.2    Women Younger Than Age 35
        6.2.3    Women Older Than Age 35
    6.3    Global Assisted Reproductive Technology Market by Application
        6.3.1    Market Overview
        6.3.2    Artificial Insemination - Intrauterine Insemination (AI-IUI)
        6.3.3    Frozen Embryo Replacement (FER)
        6.3.4    Surrogacy
        6.3.5    Ovulation Induction
        6.3.6    Others
    6.4    Global Assisted Reproductive Technology Market by End User
        6.4.1    Market Overview
        6.4.2    Hospitals
        6.4.3    Fertility Clinics
        6.4.4    Others
    6.5    Global Assisted Reproductive Technology Market by Region
        6.5.1    Market Overview
        6.5.2    North America
        6.5.3    Europe 
        6.5.4    Asia Pacific
        6.5.5    Latin America
        6.5.6    Middle East and Africa
7    North America Assisted Reproductive Technology Market
    7.1    Market Share by Country
    7.2    United States of America
    7.3    Canada
8    Europe Assisted Reproductive Technology Market
    8.1    Market Share by Country
    8.2    United Kingdom
    8.3    Germany
    8.4    France
    8.5    Italy
    8.6    Others
9    Asia Pacific Assisted Reproductive Technology Market
    9.1    Market Share by Country
    9.2    China
    9.3    Japan
    9.4    India
    9.5    ASEAN
    9.6    Australia
    9.7    Others
10    Latin America Assisted Reproductive Technology Market
    10.1    Market Share by Country
    10.2    Brazil
    10.3    Argentina
    10.4    Mexico
    10.5    Others
11    Middle East and Africa Assisted Reproductive Technology Market
    11.1    Market Share by Country
    11.2    Saudi Arabia
    11.3    United Arab Emirates
    11.4    Nigeria
    11.5    South Africa
    11.6    Others
12    Regulatory Framework
    12.1    Regulatory Overview
        12.1.1    US FDA
        12.1.2    EU EMA
        12.1.3    INDIA CDSCO
        12.1.4    JAPAN PMDA
        12.1.5    Others
13    Patent Analysis
    13.1    Analysis by Type of Patent
    13.2    Analysis by Publication year
    13.3    Analysis by Issuing Authority
    13.4    Analysis by Patent Age
    13.5    Analysis by CPC Analysis
    13.6    Analysis by Patent Valuation 
    13.7    Analysis by Key Players
14    Grants Analysis
    14.1    Analysis by year
    14.2    Analysis by Amount Awarded
    14.3    Analysis by Issuing Authority
    14.4    Analysis by Grant Application
    14.5    Analysis by Funding Institute
    14.6    Analysis by NIH Departments
    14.7    Analysis by Recipient Organization 
15    Funding and Investment Analysis
    15.1    Analysis by Funding Instances
    15.2    Analysis by Type of Funding
    15.3    Analysis by Funding Amount
    15.4    Analysis by Leading Players
    15.5    Analysis by Leading Investors
    15.6    Analysis by Geography
16    Partnership and Collaborations Analysis
    16.1    Analysis by Partnership Instances
    16.2    Analysis by Type of Partnership
    16.3    Analysis by Leading Players
    16.4    Analysis by Geography
17    Supplier Landscape
    17.1    California Cryobank
        17.1.1    Financial Analysis
        17.1.2    Product Portfolio
        17.1.3    Demographic Reach and Achievements
        17.1.4    Mergers and Acquisitions
        17.1.5    Certifications 
    17.2    Bloom Fertility Centre
        17.2.1    Financial Analysis
        17.2.2    Product Portfolio
        17.2.3    Demographic Reach and Achievements
        17.2.4    Mergers and Acquisitions
        17.2.5    Certifications
    17.3    Anecova
        17.3.1    Financial Analysis
        17.3.2    Product Portfolio
        17.3.3    Demographic Reach and Achievements
        17.3.4    Mergers and Acquisitions
        17.3.5    Certifications
    17.4    CooperSurgical
        17.4.1    Financial Analysis
        17.4.2    Product Portfolio
        17.4.3    Demographic Reach and Achievements
        17.4.4    Mergers and Acquisitions
        17.4.5    Certifications
    17.5    Merck KGaA
        17.5.1    Financial Analysis
        17.5.2    Product Portfolio
        17.5.3    Demographic Reach and Achievements
        17.5.4    Mergers and Acquisitions
        17.5.5    Certifications
    17.6    Ferring B.V.
        17.6.1    Financial Analysis
        17.6.2    Product Portfolio
        17.6.3    Demographic Reach and Achievements
        17.6.4    Mergers and Acquisitions
        17.6.5    Certifications
    17.7    FUJIFILM Irvine Scientific
        17.7.1    Financial Analysis
        17.7.2    Product Portfolio
        17.7.3    Demographic Reach and Achievements
        17.7.4    Mergers and Acquisitions
        17.7.5    Certifications
    17.8    Genea Limited
        17.8.1    Financial Analysis
        17.8.2    Product Portfolio
        17.8.3    Demographic Reach and Achievements
        17.8.4    Mergers and Acquisitions
        17.8.5    Certifications
    17.9    Nidacon International AB
        17.9.1    Financial Analysis
        17.9.2    Product Portfolio
        17.9.3    Demographic Reach and Achievements
        17.9.4    Mergers and Acquisitions
        17.9.5    Certifications
    17.10    Celmatix Inc.
        17.10.1    Financial Analysis
        17.10.2    Product Portfolio
        17.10.3    Demographic Reach and Achievements
        17.10.4    Mergers and Acquisitions
        17.10.5    Certifications
18    Key Opinion Leaders (KOL) Insights (Additional Insight)
19    Company Competitiveness Analysis (Additional Insight)

    19.1    Very Small Companies
    19.2    Small Companies
    19.3    Mid-Sized Companies
    19.4    Large Companies
    19.5    Very Large Companies
20    Payment Methods (Additional Insight)
    20.1    Government Funded
    20.2    Private Insurance
    20.3    Out-of-Pocket


*Additional insights provided are customisable as per client requirements.

Key Questions Answered in the Report

The market attained a value of about USD 15.14 billion in 2023, driven by increasing focus on bringing innovation to the field of assisted reproductive technology.

The market is anticipated to grow at a CAGR of 4.4% during the forecast period of 2024-2032, likely to reach a market value of USD 22.30 billion by 2032.

The increasing adaptation of a sedentary lifestyle among people, coupled with increased cases of infertility among men and women, are among the major factors driving the market growth. The increasing efforts of governments through their initiatives to encourage the use of assisted reproductive technology services, technological advancements, and funding activities are further aiding the market demand.

The increasing number of acquisitions between key players in the market is influencing the market growth as Baring Private Equity Asia (BPEA) EQT agreed to acquire a controlling stake in Indira IVF to expand the market reach.

The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is currently leading the global market.

Procedures of assisted reproductive technology can be performed with the help of a fresh donor, fresh nondonor, frozen donor, frozen nondonor, and embryo/egg banking.

Women younger than age 35 and older than age 35 can take advantage of this technology.

There are various applications for assisted reproductive technology such as Artificial Insemination - Intrauterine Insemination (AI-IUI), Frozen Embryo Replacement (FER), surrogacy, and ovulation induction, among others.

End users in the market are hospitals, and fertility clinics, among others.

Key players involved in the market are California Cryobank, Bloom Fertility Centre, Anecova, CooperSurgical, Merck KGaA, Ferring B.V., FUJIFILM Irvine Scientific, Genea Limited, Celmatix Inc., and Nidacon International AB.

Purchase Full Report

Mini Report

$ 3499     $2999
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5999     $5499
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 8299     $7499
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 10499     $9499
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER